Application of diramanib in preparation of medicine for preventing and/or treating lung injury and pulmonary fibrosis

The invention belongs to the technical field of medicines, and discloses application of diramanib in preparation of a medicine for preventing and/or treating lung injury and pulmonary fibrosis. According to the application disclosed by the invention, the effect target of the diramanib is Galectin 3, and the diramanib has a relatively good application prospect in preparing the medicine for preventing and/or treating the lung injury and the pulmonary fibrosis, and has the characteristics of remarkable effect and small toxic and side effects. 本发明属于医药技术领域，公开了一种迪拉马尼在制备预防和/或治疗肺损伤及肺纤维化药物中的应用。本发明首次发现迪拉马尼，作用靶标为Galectin 3，具有较好的制备预防和/或治疗肺损伤及肺纤维化药物的应用前景，具有作用效果显著，毒副作用小的特点。